KLBF - Strengthens supply chain independence amid global challenges

KLBF - Strengthens supply chain independence amid global challenges Kalbe Farma (KLBF) is focusing on building a more independent supply chain to withstand global volatility and reduce import dependence. The company is developing local raw material substitutes and expanding affordable generic drugs to support the National Health Insurance (JKN) program. As part of its expansion strategy, Kalbe is advancing in biological drug innovation, vaccine ecosystems, and specialty product development across Southeast Asia. The company is also rejuvenating its consumer and nutrition segments with affordable, ready-to-drink products, while expanding its medical equipment and export businesses. As of June 2025, net sales rose 4.59% yoy to IDR17.08 tn, supported by growth in prescription, health, and logistics segments. (Source : Bisnis Indonesia)